Giuriati Group acquires Up Pharma

Giuriati Group S.r.l. (“Giuriati Group”), a Padua-based company specialising in the development and marketing of dietary supplements, nutraceuticals and personal care products under its own and third-party brands in the pharmacy channel, has acquired 100% of Up Pharma S.r.l. (“Up Pharma”), a Mantua-based company active in the marketing of dietary supplements and nutraceuticals under its own brand name.
The acquisition is part of the strategic plan, initiated by the private equity Fund Gradiente II (managed by Gradiente SGR) and the Giuriati family, aimed at creating a reference group in terms of completeness of offer within the supplements market. With this acquisition, the group exceeds a turnover of 40 million, integrating its portfolio with specialised pro-medicinal products through a capillary network of medical reps managed by Up Pharma.
The agreement was reached with the founding partners of Up Pharma, Marzio Truffelli, Maurizio Celani and Roberto Regonati. Truffelli, in particular, will remain as CEO of Up Pharma and reinvest in Giuriati Group, to support and share the group’s development plan.

“The operating model effectively implemented by Up Pharma represents an important reference for our group. – said Gianpiero Pazzanese, CEO of Giuriati Group – It will be a pleasure to work with Marzio Truffelli to get the most out of this partnership, significantly accelerating our growth.”
“With Up Pharma we share important human and corporate values and experience in creating effective health and nutrition products to improve well-being in all moments of people’s lives. – explained Bruno Giuriati, founder and honorary chairman of the Giuriati Group – We are happy to welcome them into the group and excited to combine our strategic assets. We are certain that this new synergy, especially in this social and healthcare context, will lead us to grow together and achieve further significant results.
“This operation is an important step in the strategic project of Giuriati Group and aims to further strengthen its position in the pharmacy channel. – added Fabrizio Grasso, partner of Gradiente SGR- The business model of Up Pharma, whose strength lies in its network of medical reps, is in fact the perfect complement to the commercial network of Giuriati Group.”

For Gradiente, the transaction was led by partner Fabrizio Grasso, investment manager Stefania Lotto and associate Massimiliano Doria. Giuriati Group was assisted by Trim Corporate Finance as financial advisor, SAT Studio Legale for contracts and legal due diligence, Orsingher Ortu – Avvocati Associati for banking contracts, Epyon Consulting for accounting and tax due diligence, and Advant NCTM for structuring the transaction. The sellers were assisted by BMMS Studio Legale.
The acquisition was financed by a pool of banks consisting of Crédit Agricole Italia, which also acted as agent bank, and Intesa Sanpaolo, and assisted by the law firm Orrick.